Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioCurex gains notice of allowance for US patent:

This article was originally published in Clinica

Executive Summary

BioCurex has received a notice of allowance on a US patent relating to over 17 claims surrounding diagnostic applications for its tumour marker, RECAF. The marker is found on malignant cells from a variety of cancer types, but is absent in most normal or benign cells, says the Rancho Santa Margarita, California firm. "This patent coverage will afford us the protection to forge alliances with major companies," adds BioCurex' president, Dr Ricardo Moro.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066571

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel